[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100646843":3},{"organization":4,"armGroups":7,"interventions":20,"overallOfficials":36,"centralContacts":37,"locations":43,"responsibleParty":61,"collaborators":36,"id":63,"slug":64,"hasResults":65,"nctId":66,"briefTitle":67,"officialTitle":68,"acronym":69,"eligibilityCriteria":70,"healthyVolunteers":71,"sex":72,"minAge":73,"maxAge":74,"enrollmentInfo":75,"targetDuration":36,"studyType":78,"phases":79,"briefSummary":81,"conditions":82,"keywords":86,"overallStatus":46,"whyStopped":36,"lastUpdateSubmitDate":96,"lastUpdatePostDateStruct":97,"startDateStruct":100,"completionDateStruct":102,"leadSponsor":104,"locationsCount":105},{"fullName":5,"class":6},"Azienda Ospedaliera SS. Antonio e Biagio e Cesare Arrigo di Alessandria","OTHER",[8,14],{"label":9,"type":10,"description":11,"interventionNames":12},"Maltodextrin Group","EXPERIMENTAL","Pediatric patients receiving 125 mL of a clear liquid containing maltodextrins two hours before elective surgery as part of the ERAS preoperative fasting protocol.",[13],"Dietary Supplement: Maltodextrin Clear Liquid",{"label":15,"type":16,"description":17,"interventionNames":18},"Control Group","PLACEBO_COMPARATOR","Pediatric patients receiving 125 mL of a non-sugared clear liquid (water, tea, or chamomile) two hours before elective surgery.",[19],"Other: Non-Sugared Clear Liquid",[21,29],{"type":22,"name":23,"description":24,"armGroupLabels":25,"otherNames":26},"DIETARY_SUPPLEMENT","Maltodextrin Clear Liquid","Administration of 125 mL of a clear liquid containing maltodextrins two hours before elective pediatric surgery as part of the ERAS preoperative fasting protocol.",[9],[27,28],"Carbohydrate Loading","Maltodextrins",{"type":6,"name":30,"description":31,"armGroupLabels":32,"otherNames":33},"Non-Sugared Clear Liquid","Administration of 125 mL of a non-sugared clear liquid (water, tea, or chamomile) two hours before elective pediatric surgery.",[15],[34,35],"Placebo Beverage","Clear Liquid",null,[38],{"name":39,"role":40,"phone":41,"phoneExt":36,"email":42},"Clinical Trial Center","CONTACT","0131206893","clinicaltrialcenter@ospedale.al.it",[44],{"facility":45,"status":46,"city":47,"state":48,"zip":49,"country":50,"countryCode":51,"cosmosGeoPoint":52,"geoPoint":57,"contacts":58},"Azienda Ospedaliero-Universitaria SS. Antonio e Biagio e Cesare Arrigo","RECRUITING","Alessandria","Piedmont","15121","Italy","IT",{"type":53,"coordinates":54},"Point",[55,56],8.61007,44.90924,{"lat":56,"lon":55},[59],{"name":60,"role":40,"phone":41,"phoneExt":36,"email":42},"Pediatric Surgery Unit Clinical Trial Center",{"type":62,"investigatorFullName":36,"investigatorTitle":36,"investigatorAffiliation":36,"oldNameTitle":36,"oldOrganization":36},"SPONSOR","100646843","use-of-maltodextrins-in-the-eras-preoperative-fasting-protocol-in-pediatric-surgery-100646843",false,"NCT07686029","Use of Maltodextrins in the ERAS Preoperative Fasting Protocol in Pediatric Surgery","Use of Maltodextrins in the ERAS Preoperative Fasting Protocol in Pediatric Surgery: A Pilot Randomized Controlled Study","ERAS-MALTO","Inclusion Criteria:\n\n* Pediatric patients aged 3 to 17 years\n* Patients undergoing elective surgery in a day surgery setting\n* Surgical procedure duration less than 60 minutes\n* Written informed consent signed by a parent or legal guardian\n\nExclusion Criteria:\n\n* Maltodextrin intake within 3 hours before surgery\n* Allergy or intolerance to maltodextrins\n* Diabetes mellitus or other metabolic disorders potentially affecting study variables\n* Inadequate nutritional status based on body mass index (BMI)\n* Absence of signed informed consent by parent or legal guardian",true,"ALL","3 Years","17 Years",{"count":76,"type":77},200,"ESTIMATED","INTERVENTIONAL",[80],"NA","This monocentric prospective randomized controlled pilot study aims to evaluate the effectiveness of preoperative maltodextrin administration within an Enhanced Recovery After Surgery (ERAS) protocol in pediatric surgical patients. Children aged 3 to 8 years undergoing elective day surgery will be randomized 1:1 to receive either a maltodextrin-containing clear liquid or a non-sugared clear liquid before surgery. The study will assess preoperative anxiety, patient compliance, parental anxiety, oxidative stress markers, postoperative feeding tolerance, and postoperative recovery outcomes.",[83,84,85],"Preoperative Care","Anxiety","Pediatric Surgery",[87,88,28,89,85,90,27,91,92,93,94,95],"Enhanced Recovery After Surgery","ERAS","Preoperative Anxiety","Day Surgery","Fasting","Randomized Controlled Trial","Modified Yale Preoperative Anxiety Scale","Postoperative Recovery","Insulin Resistance","2026-07-02",{"date":98,"type":99},"2026-07-06","ACTUAL",{"date":101,"type":99},"2025-09-03",{"date":103,"type":77},"2027-06",{"name":5,"class":6},1]